MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D
touchMDT for touchENDOCRINOLOGY
Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies
The multidisciplinary team
Primary Care Physician: Dr Kevin Fernando, Berwick, UK
Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME.
For further information visit our website…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.